During the past decade, Quanta Diagnóstico e Terapia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Quanta Diagnóstico e Terapia" are "Cardiovascular Disease" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials), "Atrial Fibrillation" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Quanta Diagnóstico e Terapia" in a lesser frequency.

Most popular intervention types in "Quanta Diagnóstico e Terapia" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Tirzepatide" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quanta Diagnóstico e Terapia" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Quanta Diagnóstico e Terapia". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Quanta Diagnóstico e Terapia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Quanta Diagnóstico e Terapia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".